Baltimore, MD, United States of America

Theresa Swift-Scanlan

This inventor holds 3 USPTO granted patents. Top assignee: Johns Hopkins University. Active years: 2011-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Theresa Swift-Scanlan. Retrieved from https://idiyas.com/inventor/theresa-swift-scanlan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 253(Granted Patents)


Company Filing History:


Years Active: 2011-2016

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Theresa Swift-Scanlan

Introduction

Theresa Swift-Scanlan is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of molecular diagnostics, particularly in cancer detection. With a total of 3 patents, her work has the potential to revolutionize how certain conditions are diagnosed.

Latest Patents

One of her latest patents is focused on a method known as Quantitative multiplex methylation-specific PCR. This innovative technique provides methods for diagnosing conditions such as carcinoma, sarcoma, or leukemia, which are associated with hypermethylation of genes. The method allows for the isolation of genes from tissue samples containing as few as 50 to 1000 tumor cells. By utilizing quantitative multiplex methylation-specific PCR (QM-MSP), multiple genes can be quantitatively evaluated from samples that typically yield sufficient DNA for the analysis of only one or two genes. The DNA sequences isolated from the sample are co-amplified in an initial multiplex round of PCR. Subsequently, the methylation status of individual hypermethylation-prone gene promoter sequences is determined separately or in multiplex using a real-time PCR round that is methylation status-specific. This method not only determines the level of promoter hypermethylation but also assesses the incidence of promoter hypermethylation, allowing for a cumulative scoring of the genes in the panel. The QM-MSP method is also adaptable for high-throughput automated technology.

Career Highlights

Theresa is affiliated with The Johns Hopkins University, where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on early cancer detection and treatment strategies.

Collaborations

Some of her notable coworkers include Saraswati Vaidyanathan Sukumar and Mary Jo Fackler, who contribute to her research endeavors.

Conclusion

Theresa Swift-Scanlan's innovative work in molecular diagnostics exemplifies the critical role of inventors in advancing medical technology. Her contributions are paving the way for more effective cancer diagnosis and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…